The term "an organic modifier", as used herein, is intended to include an organic solvent or organic compound soluble in water or mixtures thereof, which modifier induces a favorable and changed selectivity between the unwanted related impurity or impurities and the GLP-1 peptide and the ion exchanger
Phase 3 clinical trials are ongoing, and regulatory submissions to bodies such as the US Food and Drug Administration (FDA) and potentially the EMA and MHRA may follow in due course, depending on trial outcomes
The rest of this guide covers the mechanisms driving lean mass loss and the exact methods to counter them
With oral options like Rybelsus and the Wegovy pill, pill-friendly logging matters more than ever
They were then reacted with corresponding Alexa Fluor 488- or 594-conjugated secondary IgG (Supplementary Table S1) at RT for 1 h
Summary: Saxenda does not directly cause missed periods, but the weight loss it produces may indirectly disrupt menstrual cycles through effects on the hypothalamic-pituitary-ovarian axis